Activity Overview
This educational activity is an archive of the live conference held on April 11, 2026.
Target Audience
This educational activity is directed toward medical oncologists,
surgical oncologists, radiation oncologists, gastroenterologists, and
hepatologists who are interested in the treatment of GI cancers. Nurse
practitioners, physician assistants, nurses, pathologists, pharmacists, and
other health care professionals involved in the treatment and management of
patients with GI cancers are invited to attend.
Learning Objectives
- Assess the clinical utility of novel molecular and genomic strategies for personalizing treatment decisions in patients with gastrointestinal (GI) cancers
- Evaluate the clinical impact of recent findings from landmark trials of emerging treatment strategies for the management of GI cancers
- Apply evolving evidence into individualized, multidisciplinary care strategies to improve outcomes for patients with GI cancers
E. Gabriela Chiorean, MD
Professor of Medicine, University of
Washington School of Medicine
Clinical Director, Gastrointestinal Oncology
Professor, Fred Hutchinson Cancer Center
Seattle, WA
Tanios S. Bekaii-Saab, MD
David F. and Margaret T. Grohne Professor of
Novel Therapeutics for Cancer Research I
Chair, Division of Hematology and Medical
Oncology
Mayo Clinic in Arizona
Phoenix, AZ
Mitesh Borad, MD
Professor of Medicine
Co-Leader, Novel Therapeutics and Therapeutic
Modalities Program
Mayo Clinic Comprehensive Cancer Center
Phoenix, AZ
Christopher Lieu, MD
Professor of Medicine
Director, GI Medical Oncology
Associate Director for Clinical Research
University of Colorado Cancer Center
Aurora, CO
Please click here to view disclosures for faculty and the staff of Physicians’ Education Resource®.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
